help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Renner, U.
Right arrow Articles by Stalla, G. K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Renner, U.
Right arrow Articles by Stalla, G. K.

Endocrinology, Vol 136, 3186-3193, Copyright © 1995 by Endocrine Society


ARTICLES

Involvement of interleukin-1 and interleukin-1 receptor antagonist in rat pituitary cell growth regulation

U Renner, CJ Newton, U Pagotto, J Sauer, E Arzt and GK Stalla
Max-Planck Institute of Psychiatry, Clinical Institute, Munich, Germany.

Interleukin-1 (IL-1), one of the mediators of the interaction between the immune and the neuroendocrine system, is well known to modulate anterior pituitary hormone secretion. As IL-1 influences growth of various cell types, we investigated whether IL-1 is also a growth factor of pituitary cells. We demonstrate that IL-1 dose and time dependently inhibits the growth of normal rat pituitary cells under serum-free conditions. The inhibitory potencies of IL-1 alpha (ED50, 8 pg/ml) and IL-1 beta (ED50, 6 pg/ml) were nearly identical. In the presence of low amounts of serum, both IL-1 alpha (ED50, 130 pg/ml) and IL-1 beta (ED50, 90 pg/ml) were less effective in inhibiting growth. The IL-1-induced growth inhibition was IL-1 receptor mediated, because both IL-1 alpha- and IL-1 beta-mediated growth suppression could be completely reversed by the IL-1 receptor antagonist, the physiological counterpart of IL-1. In the mammosomatotroph GH3 rat pituitary tumor cell line, IL-1 failed to influence growth, indicating that either IL-1 receptors are missing or the IL-1 signaling pathway is uncoupled from the growth regulation. In contrast to growth, in our rat pituitary monolayer cell culture system, IL-1 did not affect ACTH, GH, or PRL secretion as described previously. This discrepancy suggests the involvement of different mechanisms in the IL-1-induced mediation of growth and hormone secretion.


This article has been cited by other articles:


Home page
EndocrinologyHome page
U. Renner, P. Lohrer, L. Schaaf, M. Feirer, K. Schmitt, C. Onofri, E. Arzt, and G. K. Stalla
Transforming Growth Factor-{beta} Stimulates Vascular Endothelial Growth Factor Production by Folliculostellate Pituitary Cells
Endocrinology, October 1, 2002; 143(10): 3759 - 3765.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
P. Lohrer, J. Gloddek, A. C. Nagashima, Z. Korali, U. Hopfner, M. P. Pereda, E. Arzt, G. K. Stalla, and U. Renner
Lipopolysaccharide Directly Stimulates the Intrapituitary Interleukin-6 Production by Folliculostellate Cells via Specific Receptors and the p38{{alpha}} Mitogen-Activated Protein Kinase/Nuclear Factor-{{kappa}}B Pathway
Endocrinology, December 1, 2000; 141(12): 4457 - 4465.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
L. Jin, B. G. Burguera, M. E. Couce, B. W. Scheithauer, J. Lamsan, N. L. Eberhardt, E. Kulig, and R. V. Lloyd
Leptin and Leptin Receptor Expression in Normal and Neoplastic Human Pituitary: Evidence of a Regulatory Role for Leptin on Pituitary Cell Proliferation
J. Clin. Endocrinol. Metab., August 1, 1999; 84(8): 2903 - 2911.
[Abstract] [Full Text]


Home page
J. Clin. Endocrinol. Metab.Home page
J. Sauer, U. Renner, U. Hopfner, M. Lange, A. Müller, C. J. Strasburger, U. Pagotto, E. Arzt, and G. K. Stalla
Interleukin-1{beta} Enhances Interleukin-1 Receptor Antagonist Content in Human Somatotroph Adenoma Cell Cultures
J. Clin. Endocrinol. Metab., July 1, 1998; 83(7): 2429 - 2434.
[Abstract] [Full Text]


Home page
EndocrinologyHome page
C. J. Auernhammer, V. Chesnokova, and S. Melmed
Leukemia Inhibitory Factor Modulates Interleukin-1{beta}-Induced Activation of the Hypothalamo-Pituitary-Adrenal Axis
Endocrinology, May 1, 1998; 139(5): 2201 - 2208.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
U. Renner, T. Arzberger, U. Pagotto, S. Leimgruber, E. Uhl, A. Müller, M. Lange, A. Weindl, and G. K. Stalla
Heterogenous Dopamine D2 Receptor Subtype Messenger Ribonucleic Acid Expression in Clinically Nonfunctioning Pituitary Adenomas
J. Clin. Endocrinol. Metab., April 1, 1998; 83(4): 1368 - 1375.
[Abstract] [Full Text]


Home page
EndocrinologyHome page
B. L. Spangelo, D. D. Farrimond, M. Thapa, C. M. Bulathsinghala, K.-L. Bowman, A. Sareh, F. M. Hughes Jr., A. L. Goldstein, and M. Badamchian
Thymosin Fraction 5 Inhibits the Proliferation of the Rat Neuroendocrine MMQ Pituitary Adenoma and C6 Glioma Cell Lines in Vitro
Endocrinology, April 1, 1998; 139(4): 2155 - 2162.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1995 by The Endocrine Society